2802 Phase II Study of First-Line Paclitaxel (PTX) with Panitumumab (P) in Patients with Metastatic or Recurrent Head and Neck Cancer: TTCC-2009-03 Study
European journal of cancer(2015)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
European journal of cancer(2015)